Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

GAPVD1 Antikörper (N-Term)

GAPVD1 Reaktivität: Human, Maus, Hund, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN630695
  • Target Alle GAPVD1 Antikörper anzeigen
    GAPVD1 (GTPase Activating Protein and VPS9 Domains 1 (GAPVD1))
    Bindungsspezifität
    • 15
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 24
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus, Hund, Ratte
    Wirt
    • 23
    • 2
    Kaninchen
    Klonalität
    • 25
    Polyklonal
    Konjugat
    • 11
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser GAPVD1 Antikörper ist unkonjugiert
    Applikation
    • 23
    • 13
    • 13
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Spezifität
    GAPVD1 antibody was raised against the N terminal of GAPVD1
    Aufreinigung
    Affinity purified
    Immunogen
    GAPVD1 antibody was raised using the N terminal of GAPVD1 corresponding to a region with amino acids FKLFSEGLFSAKLFLTATLHEPIMQLLVEDEDHLETDPNKLIERFSPSQQ
    Top Product
    Discover our top product GAPVD1 Primärantikörper
  • Applikationshinweise
    WB: 0.25 µg/mL, IHC: 4-8 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    GAPVD1 Blocking Peptide, catalog no. 33R-2950, is also available for use as a blocking control in assays to test for specificity of this GAPVD1 antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GAPVD1 antibody in PBS
    Konzentration
    Lot specific
    Buffer
    PBS
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target
    GAPVD1 (GTPase Activating Protein and VPS9 Domains 1 (GAPVD1))
    Andere Bezeichnung
    GAPVD1 (GAPVD1 Produkte)
    Synonyme
    zgc:92666 antikoerper, GAPEX5 antikoerper, RAP6 antikoerper, 2010005B09Rik antikoerper, 4432404J10Rik antikoerper, AW108497 antikoerper, Gapex-5 antikoerper, RME-6 antikoerper, mKIAA1521 antikoerper, RGD1307479 antikoerper, GTPase activating protein and VPS9 domains 1 antikoerper, GTPase activating protein and VPS9 domains 1 S homeolog antikoerper, LOAG_00609 antikoerper, GAPVD1 antikoerper, gapvd1 antikoerper, gapvd1.S antikoerper, Gapvd1 antikoerper
    Hintergrund
    GAPVD1 acts both as a GTPase-activating protein (GAP) and a guanine nucleotide exchange factor (GEF), and participates in various processes such as endocytosis, insulin receptor internalization or LC2A4/GLUT4 trafficking. It acts as a GEF for the Ras-related protein RAB31 by exchanging bound GDP for free GTP, leading to regulate LC2A4/GLUT4 trafficking. In the absence of insulin, it maintains RAB31 in an active state and promotes a futile cycle between LC2A4/GLUT4 storage vesicles and early endosomes, retaining LC2A4/GLUT4 inside the cells. Upon insulin stimulation, it is translocated to the plasma membrane, releasing LC2A4/GLUT4 from intracellular storage vesicles. It is also involved in EGFR trafficking and degradation, possibly by promoting EGFR ubiquitination and subsequent degradation by the proteasome. It has GEF activity for Rab5 and GAP activity for Ras.
    Molekulargewicht
    166 kDa (MW of target protein)
Sie sind hier:
Kundenservice